Novartis AG Cash Flows From Used In Financing Activities Discontinued Operations
Novartis AG (NVS) reported Cash Flows From Used In Financing Activities Discontinued Operations of $3.29 billion for the 12-month period ending 2023-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations · last filed 2026-02-04
- Novartis AG cash flows from used in financing activities discontinued operations for the quarter ending 2023-06-30 was $129.00M.
- Novartis AG cash flows from used in financing activities discontinued operations for the quarter ending 2021-06-30 was -$3.00M.
- Novartis AG cash flows from used in financing activities discontinued operations for the quarter ending 2020-06-30 was -$13.00M, a 100.48% decline year-over-year.
- Novartis AG cash flows from used in financing activities discontinued operations for the quarter ending 2019-06-30 was $2.68B.
| Period end | Cash Flows From Used In Financing Activities Discontinued Operations 3 month | Cash Flows From Used In Financing Activities Discontinued Operations 6 month | Cash Flows From Used In Financing Activities Discontinued Operations 12 month |
|---|---|---|---|
| 2023-12-31 | $3.29B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $129.00M 6-K · filed 2024-07-18 | -$77.00M 6-K · filed 2024-07-18 | |
| 2022-12-31 | $119.00M 20-F · filed 2025-01-31 | ||
| 2021-12-31 | $26.00M 20-F · filed 2024-01-31 | ||
| 2021-06-30 | -$3.00M 6-K · filed 2022-07-19 | -$14.00M 6-K · filed 2022-07-19 | |
| 2020-12-31 | -$50.00M 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | -$13.00M 6-K · filed 2021-07-21 | -$26.00M 6-K · filed 2021-07-21 | |
| 2019-12-31 | $3.26B 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $2.68B 6-K · filed 2020-07-21 | $3.30B 6-K · filed 2020-07-21 | |
| 2018-12-31 | -$167.00M 20-F · filed 2021-01-26 | ||
| 2018-06-30 | -$262.00M 6-K · filed 2019-07-18 | -$315.00M 6-K · filed 2019-07-18 | |
| 2017-12-31 | -$415.00M 20-F · filed 2020-01-29 |